Register Login
Register to leave comments
  • News bot May 7, 2026, 1:10 p.m.

    📋 PALVELLA THERAPEUTICS, INC. (PVLA) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 09:09:47

    Event Type: Financial Results

    Event Details:

    PALVELLA THERAPEUTICS, INC. (PVLA) Reports the reporting period Financial Results PALVELLA THERAPEUTICS, INC. (PVLA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 206394
      • expected in second half of 2027
      • expected in the second half of 2026
      • planned for second half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 14.86K 7.87K $6.98K +88.73%
    Operating Expenses Total Other Income Expense 912.00 314.00 $598.00 +190.45%
    Operating Expenses Net Loss 15.77K 8.19K $7.58K +92.63%
    Operating Expenses Weighted Average Shares 13.09M 11.01M $2.07M +18.81%
    Loss from Operations 14.86K 7.87K $6.98K +88.73%
    Total Other Income/(Expense) 912.00 314.00 $598.00 +190.45%
    Net Loss 15.77K 8.19K $7.58K +92.63%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PALVELLA THERAPEUTICS, INC.
    • Ticker Symbol: PVLA

Search

News categories